S_mman Hyperbaric oxygen (HBO) has been proposed to reduce tumour hypoxia by increasing the amount of dissolved oxygen in the plasma. That this actually occurs has not been verified experimentally. This study was performed to explore changes in tumour oxygenation induced by treatment with normobaric and hyperbanrc oxygen and carbogen. R323OAc mammary adenocarcinomas were implanted into Fischer 344 rats. Arterial blood gases. blood pressure and heart rate were monitored. Tumour oxygenation was measured polarographically in five sets of animals. They received either normobaric 100% oxygen, hyperbaric (3 atmospheres, atm) 100% oxygen. normobaric carbogen or hyperbanrc (3 atm) carbogen (HBC) ± bretylium.
provided indirect evidence that hypoxic. radioresistant cells existed in human tumours in the 1950s. Their work led to the development of the concept of chronic, diffusion-limited hypoxia. Some of the earliest clinical efforts that were designed to overcome chronic hypoxia utilised hyperbaric oxygen (HBO) . The rationale for these trials was that higher concentrations of dissolved oxygen in the plasma would provide more gas at the capillary level and allow diffusion to occur farther into otherwise hypoxic tissue regions.
Clinical trials of HBO were initiated in the 1950s and 1960s (Brady et al.. 1981; Henk, 1986; Dische. 1991) . During this penrod, several investigators measured tumour oxygenation with simple polarographic microelectrode systems. They showed that HBO improved tumour oxygenation in animals and humans van den Brenk, 1963, 1965) .
The effects of carbogen (95% oxygen 5% carbon dioxide) breathing were also studied. There were two reasons for using carbogen: the carbon dioxide component would help to maintain tumour blood flow by counteracting oxygeninduced vasoconstriction and also increase oxygen delivery by shifting the haemoglobin-oxygen dissociation curve to the right (Rojas. 1991) . Some studies showed that carbogen breathing improved tumour oxygenation and blood flow while others did not (Kruuv et al.. 1967; Inch et al., 1970) . These studies were primarily descriptive in nature and did not explore potential mechanisms that might explain the experimental data.
A major limitation of the early polarographic measurement studies was the inability to sample more than a few points in any given tumour. The development of a computercontrolled polarographic device (pO2 histograph. Eppendorf. Hamburg, Germany) has led to a resurgence in the measurement of tumour oxygenation. Rapid in situ measurement of multiple points within a tumour is now possible.
Recently, some investigators have reintroduced carbogen into the clinic to attempt to improve tumour oxygenation. Falk et al. (1992) have demonstrated that carbogen transiently improves tumour pO, in humans. Whether or not this improvement is greater than that which would result from pure oxygen is not known.
The study reported here was performed in an animal tumour model to measure changes in tumour oxygenation induced by treatment with oxygen and carbogen under normobaric and hyperbaric conditions. Based on the existing data, our hypothesis was that HBC would increase tissue oxygenation to a greater extent than the other modalities. The study was also designed to evaluate possible physiological mechanisms that could explain any observed differences. Treatment with hyperbaric oxygen The entire apparatus, including the ventilator, the animal and the p02 histograph, were set up inside a large hyperbaric chamber. The chamber was large enough for the investigators (DB, SL, JB) to accompany the animals during the experiments. Control measurements were performed under normobaric conditions. The chamber was then presurised to 3 atm (approximately 2280 mmHg). Ambient concentration of oxygen in the chamber was 7% while the animals breathed 100% oxygen from the ventilator. The electrode was recalibrated with 7% oxygen (21% surface equivalent) and pure nitrogen. A series of 100 measurements was made after the animal had breathed pure oxygen under hyperbaric conditions for 5 min. The probe was recalibrated afterwards, and then the chamber was decompressed to 1 atm.
Treatment with hyperbaric carbogen
The procedure was similar to that for the hyperbaric oxygen expenment, but two sets of measurements were made, at 5 min and 25 min after the animal started carbogen breathing. 17mmHg (P= 0.09), and LF decreased from 0.55 to 0.17 (P = 0.02). The improvements in these oxygenation parameters with the addition of bretylium compared with those which were seen with HBC alone were highly significant (P = 0.01 and P<0.00I respectively). The improvements in tumour oxygenation from bretylium/HBC were not significantly different from those seen with HBO (P = 0.16). The augmentation in oxygenation that resulted from pretreatment with bretyhum was particularly striking in the context of the reduction in mean arterial pressure (MAP) that this drug caused. MAP fell from 112 mmHg to 65mmHg (P=0.001). Figure 2a compares the relative changes in LF for the HBO-, HBC-and bretylium/HBC-treated tumours. The baseline LFs were normalised to 1, since this parameter varied among the different groups, in order to more easily compare the changes in oxygenation. Similarly, Figure 2b shows the relative change in median P02 after 5 min of exposure to HBO, HBC and bretylium/HBC. Henk, 1986; Lustig et al., 1989 Lustig et al., , 1990 Dische, 1991; Rockwell et al., 1991 (Rojas, 1991) . Martin et al. (1993) analysed the effect of crbogen breathing on tumour oxygenation with the pO2 histograph in head and neck cancer patients with metastases to cervical lymph nodes. Median P02 improved in most tumours. However, the backward movement of the probe (0.1 mm) and the net forward probe movement (0.2mm) were kss than that used in the current study (0.3 mm and 0.4 mm respectively) and are leks than that recommended by the manufacturer (M Gunderoth, personal communication). The shorter net distance between measured points inctreases the chance that haemorrhage from a previous measurement could contaminate subsequent measurements. In such a situation, the higher paO2 from any inspired gas could erroneously lead one to conclude that tissue P02 was increased. Siemann et al. (1977) showed in an animal model that a priradiation carbogen breathing time (PEBT) of 10 minproduced a maxum radiosensitisation. As PIBTs increased up to 90 min, radiosensitivity returned to the basei leveel seen with air breathing. Similarly, Inch et al. (1970) showed that a 0.5 min cabogen PIBT more effectively radiosensitised than a 12 min PIBT. Falk et al. (1992) (Jamieson and van den Brenk, 1965; Inch al., 1970; Siemann, 1977; Falk et al., 1992 Horsman et al., 1994; Siemann et al., 1994 (Steck and Gellhorn, 1939 van den Brenk, 1963, 1965; Kruuv et al., 1967; Inch et al., 1970; Siea nn et al., 1977; Falk et al., 1992 ). An initial improvement in tumour oxygenation followed by a return towards baseline could occur if the direct effects predominated initially and were superceded by the indirect effects with additional carbogen breathing.
Many investigators have studied tumour oxygenation in awake patients or animals while the animals in the current study were anaesthetised. The anaesthea could have adversely affected blood flow and oxygen delivery. This is not hikely, however, as the baseline haemodynamic parameters (MAP, HR, arterial pO,J for these animals were not different from what has been reported when they are awake (Smith et al., 1985) . Nembutal can also depress respiratory drive which could adversely affect tissue oxygenation. We also thinkl that this is unlkely to have been a problem because the animals in this sudy were mechaniclly ventilated at rates at which they breathe when conscious. Furtermore, the experimental gases caused no 
Conclusion
The present study demonstrated that hyperbaric oxygen and hyperbaric carbogen improved tumour oxygenation in the R3230AC mammary carcinoma implanted in the hindlimb. Sympathetic-mediated vasoconstriction during carbogen breathing prevented the latter from being more effective than HBO. This mechanism also appeared to operate during normobaric carbogen breathing. It may also explain the findings obtained in the human studies of carbogen breathing. We will evaluate the extent to which these manipulations of tumour oxygenation influence the response to ionising irradiation in future animal studies.
